WATSON PHARMACEUTICALS, INC. 10,537,755 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • November 12th, 2010 • Quiver Inc. • Pharmaceutical preparations • New York
Quiver Inc., a British Virgin Islands limited liability company and a stockholder (the “Selling Stockholder”) of Watson Pharmaceuticals, Inc., a Nevada corporation (the “Company”), proposes to sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), 10,537,755 shares of common stock, par value $0.0033 per share, of the Company (the “Shares”). To the extent there are no additional Underwriters listed on Schedule 1 hereto other than you, the term Representative as used herein shall mean you, as Underwriter, and the term Underwriters shall mean either the singular or plural as the context requires. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
